Anti-Müllerian hormone: A valuable addition to the toolbox of the pediatric endocrinologist

International Journal of Endocrinology

Volumn 2013, Issue , 2013, Pages

  Josso, Nathalie ^a   Rey, Rodolfo A ^b,c   Picard, Jean Yves ^a  

^a INSERM   (France)

^b HOSPITAL DE NIÑOS RICARDO GUTIÉRREZ   (Argentina)

^c UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84893833789     PISSN: 16878337     EISSN: 16878345     Source Type: Journal    
DOI: 10.1155/2013/674105     Document Type: Review

References (74)

1. Pepinsky R. B., Sinclair L. K., Chow E. P., Mattaliano R. J., Manganaro T. F., Donahoe P. K., Cate R. L., Proteolytic processing of Müllerian inhibiting substance produces a transforming growth factor- β -like fragment. Journal of Biological Chemistry 1988 263 35 18961 18964 2-s2.0-0024203073 (Pubitemid 19016356)
2. di Clemente N., Jamin S. P., Lugovskoy A., Carmillo P., Ehrenfels C., Picard J.-Y., Whitty A., Josso N., Pepinsky R. B., Cate R. L., Processing of anti-Müllerian hormone regulates receptor activation by a mechanism distinct from TGF- β Molecular Endocrinology 2010 24 11 2193 2206 2-s2.0-78049326225 10.1210/me.2010-0273
3. Vigier B., Picard J. Y., Tran D., Production of anti-Müllerian hormone: another homology between Sertoli and granulosa cells. Endocrinology 1984 114 4 1315 1320 2-s2.0-0021288021 (Pubitemid 14134383)
4. Rey R., Sabourin J.-C., Venara M., Long W.-Q., Jaubert F., Zeller W. P., Duvillard P., Chemes H., Bidart J.-M., Anti-Müllerian hormone is a specific marker of sertoli- and granulosa-cell origin in gonadal tumors. Human Pathology 2000 31 10 1202 1208 2-s2.0-0033623491 10.1053/hupa.2000.18498
5. Grinspon R. P., Rey R. A., Anti-Müllerian hormone and sertoli cell function in paediatric male hypogonadism. Hormone Research in Paediatrics 2010 73 2 81 92 2-s2.0-77951294069 10.1159/000277140
6. Bergadá I., Milani C., Bedecarrás P., Andreone L., Ropelato M. G., Gottlieb S., Bergadá C., Campo S., Rey R. A., Time course of the serum gonadotropin surge, inhibins, and anti-Müllerian hormone in normal newborn males during the first month of life. Journal of Clinical Endocrinology & Metabolism 2006 91 10 4092 4098 2-s2.0-33749555753 10.1210/jc.2006-1079 (Pubitemid 44536890)
7. Aksglaede L., Sørensen K., Boas M., Mouritsen A., Hagen C. P., Jensen R. B., Petersen J. H., Linneberg A., Andersson A.-M., Main K. M., Skakkebæk N. E., Juul A., Changes in Anti-Müllerian Hormone (AMH) throughout the life span: a population-based study of 1027 healthy males from birth (cord blood) to the age of 69 years. Journal of Clinical Endocrinology & Metabolism 2010 95 12 5357 5364 2-s2.0-78650045339 10.1210/jc.2010-1207
8. Josso N., Rey R., Picard J. Y., Testicular anti-Müllerian hormone: clinical applications in DSD. Seminars in Reproductive Medicine 2012 30 05 364 373 10.1055/s-0032-1324719
9. Lasala C., Carré-Eusèbe D., Picard J.-Y., Rey R., Subcellular and molecular mechanisms regulating anti-Müllerian hormone gene expression in mammalian and nonmammalian species. DNA and Cell Biology 2004 23 9 572 585 2-s2.0-4544323429 10.1089/1044549041939232 (Pubitemid 39244335)
10. Lukas-Croisier C., Lasala C., Nicaud J., Bedecarrás P., Kumar T. R., Dutertre M., Matzuk M. M., Picard J.-Y., Josso N., Rey R., Follicle-stimulating hormone increases testicular Anti-Müllerian Hormone (AMH) production through Sertoli cell proliferation and a nonclassical cyclic adenosine 5′-monophosphate-mediated activation of the AMH gene. Molecular Endocrinology 2003 17 4 550 561 2-s2.0-0242440967 10.1210/me.2002-0186 (Pubitemid 36403570)
11. Rey R. A., Venara M., Coutant R., Trabut J.-B., Rouleau S., Lahlou N., Sultan C., Limal J.-M., Picard J.-Y., Lumbroso S., Unexpected mosaicism of R201H-GNAS1 mutant-bearing cells in the testes underlie macro-orchidism without sexual precocity in McCune-Albright syndrome. Human Molecular Genetics 2006 15 24 3538 3543 2-s2.0-33845363779 10.1093/hmg/ddl430 (Pubitemid 44884121)
12. Lasala C., Schteingart H. F., Arouche N., Bedecarrás P., Grinspon R. P., Picard J.-Y., Josso N., Clemente N. D., Rey R. A., SOX9 and SF1 are involved in cyclic AMP-mediated upregulationof anti-Müllerian gene expression in the testicular prepubertal Sertoli cell line SMAT1. American Journal of Physiology: Endocrinology and Metabolism 2011 301 3 E539 E547 2-s2.0-80052044795 10.1152/ajpendo.00187.2011
13. Rey R., Endocrine, paracrine and cellular regulation of postnatal anti-Müllerian hormone secretion by Sertoli cells. Trends in Endocrinology and Metabolism 1998 9 7 271 276 2-s2.0-0032171285 10.1016/S1043-2760(98)00069-1 (Pubitemid 28394974)
14. Rey R. A., Musse M., Venara M., Chemes H. E., Ontogeny of the androgen receptor expression in the fetal and postnatal testis: its relevance on sertoli cell maturation and the onset of adult spermatogenesis. Microscopy Research and Technique 2009 72 11 787 795 2-s2.0-70350540766 10.1002/jemt.20754
15. Berensztein E. B., Baquedano M. S., Gonzalez C. R., Saraco N. I., Rodriguez J., Ponzio R., Rivarola M. A., Belgorosky A., Expression of aromatase, estrogen receptor α and β androgen receptor, and cytochrome P-450scc in the human early prepubertal testis. Pediatric Research 2006 60 6 740 744 2-s2.0-33751239108 10.1203/01.pdr.0000246072.04663.bb (Pubitemid 44789519)
16. Chemes H. E., Rey R. A., Nistal M., Regadera J., Musse M., González-Peramato P., Serrano Á., Physiological androgen insensitivity of the fetal, neonatal, and early infantile testis is explained by the ontogeny of the androgen receptor expression in Sertoli cells. Journal of Clinical Endocrinology & Metabolism 2008 93 11 4408 4412 2-s2.0-57349142537 10.1210/jc.2008-0915 (Pubitemid 352789539)
17. Boukari K., Meduri G., Brailly-Tabard S., Guibourdenche J., Ciampi M. L., Massin N., Martinerie L., Picard J.-Y., Rey R., Lombès M., Young J., Lack of androgen receptor expression in Sertoli cells accounts for the absence of anti-Müllerian hormone repression during early human testis development. Journal of Clinical Endocrinology & Metabolism 2009 94 5 1818 1825 2-s2.0-66149090735 10.1210/jc.2008-1909
18. Rey R., Assessment of seminiferous tubule function (anti-Müllerian hormone). Best Practice and Research 2000 14 3 399 408 2-s2.0-0034531671 10.1053/beem.2000.0087 (Pubitemid 32000306)
19. Lee M. M., Misra M., Donahoe P. K., MacLaughlin D. T., MIS/AMH in the assessment of cryptorchidism and intersex conditions. Molecular and Cellular Endocrinology 2003 211 1-2 91 98 2-s2.0-0344084412 10.1016/j.mce.2003.09.014 (Pubitemid 37491240)
20. Lee M. M., Donahoe P. K., Silverman B. L., Hasegawa T., Hasegawa Y., Gustafson M. L., Chang Y., MacLaughlin D. T., Measurements of serum Müllerian inhibiting substance in the evaluation of children with nonpalpable gonads. The New England Journal of Medicine 1997 336 21 1480 1486 2-s2.0-0030611549 10.1056/NEJM199705223362102 (Pubitemid 27215162)
21. Josso N., Paediatric applications of anti-Müllerian hormone research. 1992 Andrea Prader Lecture. Hormone Research 1995 43 6 243 248 2-s2.0-0029011352
22. Grinspon R. P., Bedecarrás P., Ballerini M. G., Iñiguez G., Rocha A., Mantovani Rodrigues Resende E. A., Brito V. N., Milani C., Figueroa Gacitúa V., Chiesa A., Keselman A., Gottlieb S., Borges M. F., Ropelato M. G., Picard J.-Y., Codner E., Rey R. A., Early onset of primary hypogonadism revealed by serum anti-Müllerian hormone determination during infancy and childhood in trisomy 21. International Journal of Andrology 2011 34 5 e487 e498 2-s2.0-81155161803 10.1111/j.1365-2605.2011.01210.x
23. Young J., Rey R., Couzinet B., Chanson P., Josso N., Schaison G., Antimüllerian hormone in patients with hypogonadotropic hypogonadism. Journal of Clinical Endocrinology & Metabolism 1999 84 8 2696 2699 2-s2.0-0033237707 (Pubitemid 30641995)
24. Young J., Chanson P., Salenave S., Noël M., Brailly S., O'Flaherty M., Schaison G., Rey R., Testicular anti-Müllerian hormone secretion is stimulated by recombinant human FSH in patients with congenital hypogonadotropic hypogonadism. Journal of Clinical Endocrinology & Metabolism 2005 90 2 724 728 2-s2.0-14044272890 10.1210/jc.2004-0542 (Pubitemid 40279186)
25. Bastida M. G., Rey R. A., Bergadá I., Bedecarrás P., Andreone L., del Rey G., Boywitt A., Ropelato M. G., Cassinelli H., Arcari A., Campo S., Gottlieb S., Establishment of testicular endocrine function impairment during childhood and puberty in boys with Klinefelter syndrome. Clinical Endocrinology 2007 67 6 863 870 2-s2.0-36249003310 10.1111/j.1365-2265.2007. 02977.x (Pubitemid 350135129)
26. Hirsch H. J., Eldar-Geva T., Benarroch F., Rubinstein O., Gross-Tsur V., Primary testicular dysfunction is a major contributor to abnormal pubertal development in males with Prader-Willi syndrome. Journal of Clinical Endocrinology & Metabolism 2009 94 7 2262 2268 2-s2.0-67650251724 10.1210/jc.2008-2760
27. Radicioni A. F., di Giorgio G., Grugni G., Cuttini M., Losacco V., Anzuini A., Spera S., Marzano C., Lenzi A., Cappa M., Crinò A., Multiple forms of hypogonadism of central, peripheral or combined origin in males with Prader-Willi syndrome. Clinical Endocrinology 2012 76 1 72 77 2-s2.0-83455200230 10.1111/j.1365-2265.2011.04161.x
28. Siemensma E. P. C., de Lind van Wijngaarden R. F. A., Otten B. J., de Jong F. H., Hokken-Koelega A. C. S., Testicular failure in boys with Prader-Willi syndrome: longitudinal studies of reproductive hormones. Journal of Clinical Endocrinology & Metabolism 2012 97 3 E452 E459 2-s2.0-84858020081 10.1210/jc.2011-1954
29. Eiholzer U., l'Allemand D., Rousson V., Schlumpf M., Gasser T., Girard J., Grüters A., Simoni M., Hypothalamic and gonadal components of hypogonadism in boys with Prader-Labhart-Willi syndrome. Journal of Clinical Endocrinology & Metabolism 2006 91 3 892 898 2-s2.0-33644822771 10.1210/jc.2005-0902 (Pubitemid 43357755)
30. Bergadá I., Andreone L., Bedecarrás P., Ropelato M. G., Copelli S., Laissue P., Rey R. A., Campo S., Seminiferous tubule function in delayed-onset X-linked adrenal hypoplasia congenita associated with incomplete hypogonadotrophic hypogonadism. Clinical Endocrinology 2008 68 2 240 246 2-s2.0-38049177897 10.1111/j.1365-2265.2007.03026.x
31. Ferlin A., Zuccarello D., Zuccarello B., Chirico M. R., Zanon G. F., Foresta C., Genetic alterations associated with cryptorchidism. Journal of the American Medical Association 2008 300 19 2271 2276 2-s2.0-56649124562 10.1001/jama.2008.668
32. Virtanen H. E., Toppari J., Epidemiology and pathogenesis of cryptorchidism. Human Reproduction Update 2008 14 1 49 58 2-s2.0-37549033861 10.1093/humupd/dmm027
33. Misra M., MacLaughlin D. T., Donahoe P. K., Lee M. M., Massachusetts M., Measurement of Müllerian inhibiting substance facilitates management of boys with microphallus and cryptorchidism. Journal of Clinical Endocrinology & Metabolism 2002 87 8 3598 3602 2-s2.0-0036342730 10.1210/jc.87.8.3598 (Pubitemid 34879501)
34. Suomi A.-M., Main K. M., Kaleva M., Schmidt I. M., Chellakooty M., Virtanen H. E., Boisen K. A., Damgaard I. N., Kai C. M., Skakkebæk N. E., Toppari J., Hormonal changes in 3-month-old cryptorchid boys. Journal of Clinical Endocrinology & Metabolism 2006 91 3 953 958 2-s2.0-33644831889 10.1210/jc.2004-2318 (Pubitemid 43357764)
35. Bay K., Virtanen H. E., Hartung S., Ivell R., Main K. M., Skakkebaek N. E., Andersson A.-M., Toppari J., Boisen K., Chellakooty M., Damgaard I. N., Kaleva M., Schmidt I. M., Suomi A.-M., Insulin-like factor 3 levels in cord blood and serum from children: effects of age, postnatal hypothalamic-pituitary- gonadal axis activation, and cryptorchidism. Journal of Clinical Endocrinology & Metabolism 2007 92 10 4020 4027 2-s2.0-35349011589 10.1210/jc.2007-0974 (Pubitemid 47607655)
36. Kollin C., Stukenborg J. B., Nurmio M., Boys with undescended testes: endocrine, volumetric and morphometric studies on testicular function before and after orchidopexy at nine months or three years of age. Journal of Clinical Endocrinology & Metabolism 2012 97 4588 4595
37. Grinspon R. P., Ropelato M. G., Bedecarrás P., Loreti N., Ballerini M. G., Gottlieb S., Campo S. M., Rey R. A., Gonadotrophin secretion pattern in anorchid boys from birth to pubertal age: pathophysiological aspects and diagnostic usefulness. Clinical Endocrinology 2012 76 5 698 705 2-s2.0-84859636519 10.1111/j.1365-2265.2011.04297.x
38. Ankarberg-Lindgren C., Westphal O., Dahlgren J., Testicular size development and reproductive hormones in boys and adult males with Noonan syndrome: a longitudinal study. European Journal of Endocrinology 2011 165 1 137 144 2-s2.0-79959463088 10.1530/EJE-11-0092
39. Feyaerts A., Forest M. G., Morel Y., Mure P.-Y., Morel-Journel N., Mallet D., Nicolino M., Chatelain P., David M., Mouriquand P., Endocrine screening in 32 consecutive patients with hypospadias. Journal of Urology 2002 168 2 720 725 2-s2.0-0036071858 (Pubitemid 34793350)
40. Rey R. A., Codner E., Iñíguez G., Bedecarrás P., Trigo R., Okuma C., Gottlieb S., Bergadá I., Campo S. M., Cassorla F. G., Low risk of impaired testicular sertoli and leydig cell functions in boys with isolated hypospadias. Journal of Clinical Endocrinology & Metabolism 2005 90 11 6035 6040 2-s2.0-27744583396 10.1210/jc.2005-1306 (Pubitemid 41606522)
41. Rey R. A., Belville C., Nihoul-Fékété C., Evaluation of gonadal function in 107 intersex patients by means of serum antimüllerian hormone measurement. Journal of Clinical Endocrinology & Metabolism 1999 84 627 631 (Pubitemid 29075696)
42. Plotton I., Gay C. L., Bertrand A. M., AMH determination is essential for the management of 46, XY DSD patients. Pediatric Research 2009 72 supplement 3 365
43. Hagen C. P., Aksglaede L., Sørensen K., Main K. M., Boas M., Cleemann L., Holm K., Gravholt C. H., Andersson A.-M., Pedersen A. T., Petersen J. H., Linneberg A., Kjaergaard S., Juul A., Serum levels of anti-Müllerian hormone as a marker of ovarian function in 926 healthy females from birth to adulthood and in 172 turner syndrome patients. Journal of Clinical Endocrinology & Metabolism 2010 95 11 5003 5010 2-s2.0-78049492520 10.1210/jc.2010-0930
44. Rey R., Mebarki F., Forest M. G., Mowszowicz I., Cate R. L., Morel Y., Chaussain J.-L., Josso N., Anti-Müllerian hormone in children with androgen insensitivity. Journal of Clinical Endocrinology & Metabolism 1994 79 4 960 964 2-s2.0-0028171015 10.1210/jc.79.4.960 (Pubitemid 24342231)
45. Stuchi-Perez E. G., Hackel C., Oliveira L. E. C., Ferraz L. F. C., Oliveira L. C., Nunes-Silva D., Toralles M. B., Steinmetz L., Damiani D., Maciel-Guerra A. T., Guerra G. Jr., Diagnosis of 5 α -reductase type 2 deficiency: contribution of anti-Müllerian hormone evaluation. Journal of Pediatric Endocrinology and Metabolism 2005 18 12 1383 1389 2-s2.0-30944433182 (Pubitemid 43109375)
46. Bouvattier C., Carel J.-C., Lecointre C., David A., Sultan C., Bertrand A.-M., Morel Y., Chaussain J.-L., Postnatal changes of T, LH, and FSH in 46,XY infants with mutations in the AR gene. Journal of Clinical Endocrinology & Metabolism 2002 87 1 29 32 2-s2.0-0036149960 10.1210/jc.87.1.29 (Pubitemid 34084665)
47. Lang-Muritano M., Biason-Lauber A., Gitzelmann C., Belville C., Picard Y., Schoenle E. J., A novel mutation in the anti-Müllerian hormone gene as cause of persistent Müllerian duct syndrome. European Journal of Pediatrics 2001 160 11 652 654 2-s2.0-0034764958 (Pubitemid 33030293)
48. El-Gohary M. A., Laparoscopic management of persistent Müllerian duct syndrome. Pediatric Surgery International 2003 19 7 533 536 2-s2.0-0142183193 10.1007/s00383-003-0984-7 (Pubitemid 37309882)
49. Martin E. L., Bennett A. H., Cromie W. J., Persistent Müllerian duct syndrome with transverse testicular ectopia and spermatogenesis. Journal of Urology 1992 147 6 1615 1617 2-s2.0-0026609945
50. Naouar S., Maazoun K., Sahnoun L., Jouini R., Ksia A., Elezzi O., Krichene I., Mekki M., Belghith M., Nouri A., Transverse testicular ectopia: a three-case report and review of the literature. Urology 2008 71 6 1070 1073 2-s2.0-44649101498 10.1016/j.urology.2007.11.133
51. Abduljabbar M., Taheini K., Picard J. Y., Mutations of the AMH type II receptor in two extended families with persistent Müllerian duct syndrome: lack of phenotype/genotype correlation. Hormone Research in Paediatrics 2012 77 291 297 10.1159/000338343
52. Chaabane W., Jarboui L., Sahnoun A., Daoud E., Hadjsliman M., Fakhfekh H., Bahloul A., Mhiri M. N., Persistent Müllerian duct syndrome with torsion of a transverse testicular ectopia: first reported case. Urology 2010 76 1 65 66 2-s2.0-77955893571 10.1016/j.urology.2009.10.021
53. Imbeaud S., Rey R., Berta P., Chaussain J.-L., Wit J.-M., Lustig R. H., de Vroede M. A. M., Picard J.-Y., Josso N., Testicular degeneration in three patients with the persistent Müllerian duct syndrome. European Journal of Pediatrics 1995 154 3 187 190 2-s2.0-0028942092 10.1007/s004310050272
54. Josso N., Fekete C., Cachin O., Persistence of Müllerian ducts in male pseudohermaphroditism, and its relationship to cryptorchidism. Clinical Endocrinology 1983 19 2 247 258 2-s2.0-0020577410 (Pubitemid 13073291)
55. Vandersteen D. R., Chaumeton A. K., Ireland K., Tank E. S., Surgical management of persistent Müllerian duct syndrome. Urology 1997 49 6 941 945 2-s2.0-0030912949 10.1016/S0090-4295(97)00104-0 (Pubitemid 27246967)
56. Brandli D. W., Akbal C., Eugsster E., Hadad N., Havlik R. J., Kaefer M., Persistent Müllerian duct syndrome with bilateral abdominal testis: surgical approach and review of the literature. Journal of Pediatric Urology 2005 1 6 423 427 2-s2.0-32544440939 10.1016/j.jpurol.2005.03.011 (Pubitemid 43230267)
57. Josso N., Belville C., di Clemente N., Picard J.-Y., AMH and AMH receptor defects in persistent Müllerian duct syndrome. Human Reproduction Update 2005 11 4 351 356 2-s2.0-21244498141 10.1093/humupd/dmi014 (Pubitemid 40895464)
58. Belville C., van Vlijmen H., Ehrenfels C., Pepinsky B., Rezaie A. R., Picard J.-Y., Josso N., di Clemente N., Cate R. L., Mutations of the anti-Müllerian hormone gene in patients with persistent Müllerian duct syndrome: biosynthesis, secretion, and processing of the abnormal proteins and analysis using a three-dimensional model. Molecular Endocrinology 2004 18 3 708 721 2-s2.0-1542327546 10.1210/me.2003-0358 (Pubitemid 38328214)
59. Cate R. L., Mattaliano R. J., Hession C., Isolation of the bovine and human genes for Müllerian inhibiting substance and expression of the human gene in animal cells. Cell 1986 45 5 685 698 2-s2.0-0022499726 (Pubitemid 16063132)
60. Cohen-Haguenauer O., Picard J. Y., Mattei M.-G., Mapping of the gene for anti-Müllerian hormone to the short arm of human chromosome 19. Cytogenetics and Cell Genetics 1987 44 1 2 6 2-s2.0-0023154197 (Pubitemid 17037164)
61. Knebelmann B., Boussin L., Guerrier D., Legeai L., Kahn A., Josso N., Picard J.-Y., Anti-Müllerian hormone bruxelles: a nonsense mutation associated with the persistent Müllerian duct syndrome. Proceedings of the National Academy of Sciences of the United States of America 1991 88 9 3767 3771 2-s2.0-0025920616 (Pubitemid 21916705)
62. Baarends W. M., van Helmond M. J. L., Post M., van der Schoot P. J. C. M., Hoogerbrugge J. W., de Winter J. P., Uilenbroek J. T. J., Karels B., Wilming L. G., Meijers J. H. C., Themmen A. P. N., Grootegoed J. A., A novel member of the transmembrane serine/threonine kinase receptor family is specifically expressed in the gonads and in mesenchymal cells adjacent to the Müllerian duct. Development 1994 120 1 189 197 2-s2.0-0027953410
63. di Clemente N., Wilson C., Faure E., Boussin L., Carmillo P., Tizard R., Picard J.-Y., Vigier B., Josso N., Cate R., Cloning, expression, and alternative splicing of the receptor for anti-Müllerian hormone. Molecular Endocrinology 1994 8 8 1006 1020 2-s2.0-0028106201 10.1210/me.8.8.1006 (Pubitemid 24254008)
64. Clarke T. R., Hoshiya Y., Yi S. E., Liu X., Lyons K. M., Donahoe P. K., Müllerian inhibiting substance signaling uses a Bone Morphogenetic Protein (BMP)-like pathway mediated by ALK2 and induces Smad6 expression. Molecular Endocrinology 2001 15 6 946 959 2-s2.0-0034994419 10.1210/me.15.6.946 (Pubitemid 32510641)
65. Orvis G. D., Jamin S. P., Kwan K. M., Mishina Y., Kaartinen V. M., Huang S., Roberts A. B., Umans L., Huylebroeck D., Zwijsen A., Wang D., Martin J. F., Behringer R. R., Functional redundancy of TGF-beta family type i receptors and receptor-smads in mediating anti-Müllerian hormone-induced Müllerian duct regression in the mouse. Biology of Reproduction 2008 78 6 994 1001 2-s2.0-44349154797 10.1095/biolreprod.107.066605 (Pubitemid 351749287)
66. Jamin S. P., Arango N. A., Mishina Y., Hanks M. C., Behringer R. R., Requirement of Bmpr1a for Müllerian duct regression during male sexual development. Nature Genetics 2002 32 3 408 410 2-s2.0-0036842115 10.1038/ng1003 (Pubitemid 35266116)
67. Gouédard L., Chen Y.-G., Thevenet L., Racine C., Borie S., Lamarre I., Josso N., Massaguè J., di Clemente N., Engagement of bone morphogenetic protein type IB receptor and Smad1 signaling by anti-Müllerian hormone and its type II receptor. Journal of Biological Chemistry 2000 275 36 27973 27978 2-s2.0-0034623238 10.1074/jbc.M002704200
68. Belville C., Jamin S. P., Picard J.-Y., Josso N., di Clemente N., Role of type I receptors for anti-Müllerian hormone in the SMAT-1 Sertoli cell line. Oncogene 2005 24 31 4984 4992 2-s2.0-23744504542 10.1038/sj.onc.1208686 (Pubitemid 41129102)
69. Imbeaud S., Faure E., Lamarre I., Mattei M.-G., di Clemente N., Tizard R., Carre-Eusebe D., Belville C., Tragethon L., Tonkin C., Nelson J., McAuliffe M., Bidart J.-M., Lababidi A., Josso N., Cate R. L., Picard J.-Y., Insensitivity to anti-Müllerian hormone due to a mutation in the human anti-Müllerian hormone receptor. Nature Genetics 1995 11 4 382 388 2-s2.0-0028972867
70. Hoshiya M., Christian B. P., Cromie W. J., Kim H., Zhan Y., MacLaughlin D. T., Donahoe P. K., Persistent Müllerian duct syndrome caused by both a 27-bp deletion and a novel splice mutation in the MIS type II receptor gene. Birth Defects Research A 2003 67 10 868 874 2-s2.0-0242349758 10.1002/bdra.10091 (Pubitemid 37337569)
71. Klosowski S., Abriak A., Morisot C., Bayart H. C., Belville C., Thelliez P., Gottrand F., Croquette M. F., Deroubaix P., Jejunal atresia and persistent Müllerian duct syndrome. Archives de Pediatrie 1997 4 12 1264 1265 2-s2.0-0031300857
72. Josso N., di Clemente N., Transduction pathway of anti-Müllerian hormone, a sex-specific member of the TGF- β family. Trends in Endocrinology and Metabolism 2003 14 2 91 97 2-s2.0-0037731743 10.1016/S1043-2760(03)00005-5 (Pubitemid 36733922)
73. Kobayashi A., Allison Stewart C., Wang Y., Fujioka K., Thomas N. C., Jamin S. P., Behringer R. R., β -catenin is essential for Müllerian duct regression during male sexual differentiation. Development 2011 138 10 1967 1975 2-s2.0-79955565762 10.1242/dev.056143
74. Tanwar P. S., Zhang L., Tanaka Y., Taketo M. M., Donahoe P. K., Teixeira J. M., Focal Müllerian duct retention in male mice with constitutively activated β -catenin expression in the Müllerian duct mesenchyme. Proceedings of the National Academy of Sciences of the United States of America 2010 107 37 16142 16147 2-s2.0-77958009978 10.1073/pnas.1011606107